LISELOTTE ADDEA-AMOAKO: Open Payments
NPI 1518208784 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 39 payments from 10 companies in 2025. Trend: 2023 $242 · 2024 $778 · 2025 $1,011
Food & beverage: $723Education: $288
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $373 |
| Sumitomo Pharma America, Inc. | 12 | $231 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Lundbeck LLC | 3 | $78 |
| Paratek Pharmaceuticals, Inc. | 3 | $77 |
| Novo Nordisk Inc | 2 | $43 |
| SHIELD THERAPEUTICS INC | 1 | $41 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
Products named: GEMTESA, REXULTI, Veozah, XHANCE, ACCRUFER, PAXLOVID, The Cologuard Plus Collection Kit, NUZYRA.
Industry payments across TX — which companies pay providers there.
